Clinical report from the pilot USA kernicterus registry (1992 to 2004)

Journal of Perinatology

Volumn 29, Issue , 2009, Pages S25-S45

  Johnson, L ^a   Bhutani, V K ^b   Karp, K ^a   Sivieri, E M ^a   Shapiro, S M ^c  

^a Pennsylvania Center for Kernicterus   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bilirubin hyperbilirubinemia; Bilirubin Induced neurological dysfunction; Kernicterus; Newborn jaundice; Well babies

Indexed keywords

BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

BILIRUBIN BLOOD LEVEL; BREAST FEEDING; CLINICAL FEATURE; COHORT ANALYSIS; DEHYDRATION; DISEASE COURSE; ENTEROHEPATIC CIRCULATION; ENZYME DEFICIENCY; EXCHANGE BLOOD TRANSFUSION; GENETIC DISORDER; GESTATIONAL AGE; HEMOLYSIS; HEMOLYTIC ANEMIA; HIGH RISK PATIENT; HOME DELIVERY; HOSPITAL READMISSION; HUMAN; HYPERBILIRUBINEMIA; INFANT; INFANT MORTALITY; INFECTION; KERNICTERUS; LACTATION; MAJOR CLINICAL STUDY; NEUROTOXICITY; NEWBORN JAUNDICE; OUTPATIENT CARE; PATIENT TRANSPORT; PHOTOTHERAPY; PILOT STUDY; PREMATURITY; PROTEIN SYNTHESIS; REGISTER; REVIEW; RISK ASSESSMENT; RISK FACTOR; ROOT CAUSE ANALYSIS; TERTIARY HEALTH CARE; TREATMENT RESPONSE; UNITED STATES;

BILIRUBIN; CONTINUITY OF PATIENT CARE; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; INCIDENCE; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; PATIENT READMISSION; PHOTOTHERAPY; REGISTRIES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 59549083204     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.211     Document Type: Review

References (52)

1. Van Praagh R. Diagnosis of kernicterus in the neonatal period. Pediatrics 1961; 28: 870–874.
2. Jones MH, Sands R, Hyman CB, Sturgeon P, Koch FP. Longitudinal study of the incidence of central nervous system damage following erythroblastosis fetalis. Pediatrics 1954; 14: 346.
3. Perlstein M. Neurologic sequelae of erythroblastosis fetalis. Am J Dis Child 1950; 79: 605–606.
4. Volpe JJ. Bilirubin and brain injury. In: Volpe JJ (ed). Neurology of the Newborn, 4th edn. 2001.
5. Johnson L, Brown AK, Bhutani V. BINDFa clinical score for bilirubin induced neurologic dysfunction in newborns. Pediatrics 1999; 104: 746.
6. Bhutani VK, Johnson L, Keren R. Acute bilirubin encephalopathyybefore it is too late. Contemporary Pediatr 2005; 54–74. http://www.modernmedicine.com/modernmedicine/Features/Treating-acute-bilirubin-encephalopathy–before-it/ArticleStandard/Article/detail/161379.
7. Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005; 25(1): 54–59.
8. Shapiro SM, Bhutani VK, Johnson L. Hyperbilirubinemia and kernicterus. Clin Perinatol 2006; 33(2): 387–410.
9. Odell GB, Storey GNB, Rosenberg LA. Studies in kernicterus. III. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr 1970; 76: 12–21.
10. Johnson L, Boggs TR. Bilirubin-dependent brain damage: incidence and indication for treatment. In: Odell GB, Schaffer R, Simopoulous AP (eds). Phototherapy in the Newborn: An Overview. National Academy of Sciences: Washington, DC, 1974, pp 122–149.
11. Diamond I. Kernicterus: revised concepts of pathogenesis and management. Pediatrics 1966; 38: 539–542.
12. Zuelzer WW, Mudgett RT. Kernicterus; etiologic study based on an analysis of 55 cases. Pediatrics 1950; 6(1:3): 452–474.
13. American Academy of Pediatrics, Provisional Committee for Quality Improvement. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994; 94: 558–565.
14. Palmer RH, Ezhuthachan S, Newman C, Maisels MJ, Testa MA. Management of hyperbilirubinemia in newborns: measuring performance using a benchmarking model. Pediatrics 2004; 114(3): 902.
15. Johnson LH, Bhutani VK. Guidelines for management of the jaundiced term and nearterm infant. Clin Perinatol 1998; 25: 555–574.
16. Johnson L, Brown AK, Bhutani VK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002; 93: 488–494.
17. American Academy of Pediatrics Clinical Practice Guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297–316.
18. Hansen TW. Acute management of extreme neonatal jaundiceFthe potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 1997; 86(8): 843–846.
19. Ip S, Chung M, Kulig J, O’Brien R, Sege R, Glicken S, et al., Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114: e130–e153.
20. Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006; 118(3): 1207–1214.
21. Palmer RH, Keren R, Maisels MJ, Yeargin-Allsopp M. National Institute of Child Health and Human Development (NICHD) conference on kernicterus: a population perspective on prevention of kernicterus. J Perinatol 2004; 24(11): 723–725.
22. Stevenson DK, Wong RJ, Vreman HJ, McDonagh AF, Maisels MJ, Lightner DA. NICHD Conference on Kernicterus: research on prevention of bilirubin-induced brain injury and kernicterus: bench-to-bedsideFdiagnostic methods and prevention and treatment strategies. J Perinatol 2004; 24: 521–525.
23. Sheridan SE. Parents of infants and children with kernicterus. J Perinatol 2005; 25(4): 227–228.
24. Bhutani VK, Johnson LH, Maisels MJ, Newman TB, Phibbs C, Stark AR et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24: 650–662.
25. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103(1): 6–14.
26. Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ et al. Prediction of hyperbilirubinemia in term and near-term newborn infants. Pediatrics 2001; 108: 31–39.
27. Bhutani VK, Johnson LH, Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin North Am 2004; 51(4): 843–861.
28. Institute of Medicine. Toerr is human: building a safer health system. 1 November 1999. http://www.iom.edu/?id¼12735.
29. Joint Commission Accrediting Hospital Organizations (JCAHO). Revised guidance to help prevent kernicterus. Sentinel Event Alert 2004; 31(31): 1–2.
30. Bhutani VK, Johnson L. Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol 2006; 30(2): 89–97.
31. Ebbesen F, Nyboe J. Postnatal changes in the ability of plasma albumin to bind bilirubin. Acta Paediatr Scand 1983; 72: 665–670.
32. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 2000; 89: 1213–1217.
33. Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen-Bjergaard L, Petersen JR et al. Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr 2005; 94: 59–64.
34. Manning DJ, Maxwell MJ, Todd PJ, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child. Fetal Neonatal Ed. Online publication. 0.1136/adc.2006.105361. http://fn.bmj.com/cgi/rapidpdf/adc.2006.105361v1.
35. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006; 175: 587–590.
36. Facchini FP, Mezzacappa MA, Rosa IR, Mezzacappa Filho F, Aranha-Netto A, Marba ST. Follow-up of neonatal jaundice in term and late premature newborns. J Pediatr (Rio J) 2007; 83(4): 313–322.
37. Kaplan M, Bromiker R, Schimmel MS, Algur N, Hammerman C. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience. J Pediatr 2007; 150(4): 412–417.
38. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs 2006; 35(4): 444–455.
39. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 2006; 117: e855–e862.
40. Bhutani VK, Donn SM, Johnson LH. Risk management of severe neonatal hyperbilirubinemia: to prevent kernicterus. Clin Perinatol 2005; 32(1): 125–139.
41. Susan E. Sheridan, consumer, Testimony to the National Summit on Medical Errors and Patient Safety Research, Washington, DC, 11 September 2000, www.quic.gov/summit/wsheridan.htm (accessed 21 March 2003).
42. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dl or more in a large managed care organization. Pediatrics 2003; 111(6 Pt 1): 1303–1311.
43. Lucey JE. Kernicterus: revised concepts of pathogenesis and management. Commentary. Pediatrics 1966; 38: 545–546.
44. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006; 117: 474–485.
45. Lannon C, Stark AR. Closing the gap between guidelines and practice: ensuring safe and healthy beginnings. Pediatrics 2004; 114: 494–496.
46. Center for Disease Control and Prevention. http://www.cdc.gov/ncbddd/dd/kernichome.htm.
47. Association of Women’s Health, Obstetrics and Neonatal Nurses. http://www.awhonn.org/awhonn/product.detail.do?productCode¼HNPP-CD-2NDI.
48. Smitherman H, Stark AR, Bhutani VK. Early recognition of neonatal hyperbilirubinemia and its emergent management. Semin Fetal Neonatal Med 2006; 11: 214–224.
49. California Perinatal Quality Care Collaborative. http://www.cpqcc.org/quality_improvement.htm.
50. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 2008; 121(1): e170–e179.
51. Lazarus C, Avchen RN. Neonatal hyperbilirubinemia management: a model for change. J Perinatol 2009; 29(Suppl 1): S58–S60.
52. Stark AR, Lannon CM. Systems changes to prevent severe hyperbilirubinemia and promote breastfeeding: pilot approaches. J Perinatol 2009; 29(Suppl 1): S53–S57.